Bottom line
FHLC vs JDOC: the short answer
FHLC (Fidelity MSCI Health Care Index ETF) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 63% by weight.
But FHLC is far broader, holding 337 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
FHLC is cheaper at 0.084% vs 0.65% — a difference of $57 a year per $10,000 invested.
Over one year, JDOC returned +14.9% vs +2.6% for FHLC (reporting dates differ).
Updated Nov 19, 2026
FHLC vs JDOC side by side
| FHLC | JDOC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Fidelity | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.084% | 0.65% |
| Annual cost per $10k | $8.4 | $65 |
| 10-yr cost on $10k (prospectus) | $108 | $810 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +2.6% | +14.9% |
| 5-yr return (annualized) | +7.2% | — |
| 10-yr return (annualized) | +8.8% | — |
| Best quarter | +16.4% | +11.3% |
| Worst quarter | −13.1% | −11.9% |
| Net assets (fund) | $3.3B | $9.1M |
| Number of holdings | 337 | 61 |
| Portfolio turnover | 3% | 92% |
| Returns as of | Nov 30, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHLC | JDOC | Difference |
|---|---|---|---|
| 2024 | +2.6% | −0.6% | +3.2% |
Source: Fund prospectus bar charts
Holdings overlap
15 of FHLC's top 25 holdings also appear in JDOC's top 25.
| Holding | FHLC | JDOC |
|---|---|---|
| Eli Lilly & Co | 13.35% | 7.76% |
| Johnson & Johnson | 8.93% | 4.82% |
| AbbVie Inc | 6.42% | 7.85% |
| UnitedHealth Group Inc | 5.44% | 5.85% |
| Merck & Co Inc | 4.66% | 4.82% |
| Thermo Fisher Scientific Inc | 3.09% | 3.73% |
| Abbott Laboratories | 2.66% | 3.11% |
| Bristol-Myers Squibb Co | 1.93% | 3.57% |
| CVS Health Corp | 1.92% | 2.83% |
| Intuitive Surgical Inc | 1.82% | 1.93% |
| Danaher Corp | 1.80% | 2.16% |
| Stryker Corp | 1.62% | 2.23% |
| Regeneron Pharmaceuticals Inc | 1.15% | 1.60% |
| Cencora Inc | 0.83% | 2.07% |
| Cardinal Health Inc | 0.78% | 1.51% |
Source: SEC Form N-PORT
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between FHLC and JDOC?
Which is cheaper, FHLC or JDOC?
Should I own both FHLC and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.